Medicinova Share Price

Medicinova Share Price

NASDAQ: MNOV | Micro Cap | Healthcare
$1.28
+$0.00 (0.39%) Last updated on 21 Nov, 2026 | 01:22 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Medicinova Stock Performance

Open
$1.29
Prev. Close
$1.28
Circuit Range
N/A
Day Range
$1.28 - $1.29
Year Range
$1.24 - $3.89
Volume
937
Average Traded
$1.29

Medicinova Share Price Today

As of 22 November 2026, Medicinova Inc's share price is $1.28. The stock opened at $1.29, compared to its previous close of $1.28. During today's trading session, Medicinova Inc's share price traded between $1.28 and $1.29, with an average price of $1.29. Over the past 52 weeks, the stock has recorded a high of $3.89 and a low of $1.24. In terms of performance, Medicinova Inc's share price has declined by 5.86% over the last six months and is down 11.99% on a year-on-year basis.

Medicinova Share Price Chart

Line chart of the Medicinova price trend over the selected period. The price rose overall, ranging from 1.27 to 1.30, ending at 1.28.
$1.28$1.29
L
Show Current Price
H

Medicinova Stock Fundamentals & Key Indicators

Market Cap
$63.05M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.21
Revenue (TTM)
$410.00M
Return On Equity (TTM)
-25.66%
Profit Margin
-2926.83%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-1.43%

Medicinova Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.15$0.19$0.46$0.14
Net Profit-$2.80-$2.59-$2.31-$2.84
Net Profit Margin-1866.67%-1363.16%-502.17%-2028.57%
Income ChangeN/A7.50%10.81%-22.94%

Medicinova Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$1.00$0.00$0.41
Net Profit-$14.07-$8.57-$11.05-$12.00
Net Profit MarginN/A-857.00%N/A-2926.83%
Income ChangeN/A39.09%-28.94%-8.60%

Medicinova Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets14.6114.815.115.17
Current Assets30.9941.0751.1758.99
Total Assets45.655.8866.2774.15
Non Current Liabilities0.220.410.610.73
Current Liabilities3.82.963.283.19
Total Liabilities4.023.373.893.91
Shareholders' Equity41.5952.562.3870.24

Medicinova Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-9.81-10.64-7.43-12.58
Investing0.00.039.91-40.01
Financing0.240.00.00.01

About Medicinova

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

Medicinova Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.43
$1.28
-8.87%
Oct 2026
$1.66
$1.41
-16.57%
Sep 2026
$1.53
$1.69
+12.67%
Aug 2026
$1.32
$1.50
+12.78%
Jul 2026
$1.38
$1.33
+0.76%
Jun 2026
$1.34
$1.32
-3.30%
May 2026
$1.41
$1.36
-5.86%
Apr 2026
$1.40
$1.45
+5.84%
Mar 2026
$1.41
$1.37
-6.80%
Feb 2026
$1.67
$1.47
-15.52%
Jan 2026
$1.40
$1.74
+33.85%
Dec 2025
$1.47
$1.30
-10.96%

Medicinova Share Price FAQs